Lee's Pharmaceutical (00950) said its profit attributable to the owners for the three months ended 31 March 2018 rose 51.3% year-on-year to HK$70.18 million.
Basic and diluted earnings per share were HK11.87 cents and HK11.77 cents.
Revenue amounted to HK$282 million, an increase of 24.6% from a year earlier.
Gross profit grew 28.8% year-on-year to HK$193 million. The Group's overall gross profit margin held at 68.3%, improved by 2.2 percentage points as to 66.1% achieved in the same quarter of 2017.